These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 1482662)

  • 1. Incompletely processed N-glycans of serum glycoproteins in congenital dyserythropoietic anaemia type II (HEMPAS).
    Fukuda MN; Gaetani GF; Izzo P; Scartezzini P; Dell A
    Br J Haematol; 1992 Dec; 82(4):745-52. PubMed ID: 1482662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HEMPAS disease: genetic defect of glycosylation.
    Fukuda MN
    Glycobiology; 1990 Sep; 1(1):9-15. PubMed ID: 2136385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incomplete synthesis of N-glycans in congenital dyserythropoietic anemia type II caused by a defect in the gene encoding alpha-mannosidase II.
    Fukuda MN; Masri KA; Dell A; Luzzatto L; Moremen KW
    Proc Natl Acad Sci U S A; 1990 Oct; 87(19):7443-7. PubMed ID: 2217175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HEMPAS. Hereditary erythroblastic multinuclearity with positive acidified serum lysis test.
    Fukuda MN
    Biochim Biophys Acta; 1999 Oct; 1455(2-3):231-9. PubMed ID: 10571015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Congenital dyserythropoietic anaemia type II (HEMPAS) and its molecular basis.
    Fukuda MN
    Baillieres Clin Haematol; 1993 Jun; 6(2):493-511. PubMed ID: 8043936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary defect of congenital dyserythropoietic anemia type II. Failure in glycosylation of erythrocyte lactosaminoglycan proteins caused by lowered N-acetylglucosaminyltransferase II.
    Fukuda MN; Dell A; Scartezzini P
    J Biol Chem; 1987 May; 262(15):7195-206. PubMed ID: 2953718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defect in glycosylation of erythrocyte membrane proteins in congenital dyserythropoietic anaemia type II (HEMPAS).
    Fukuda MN; Papayannopoulou T; Gordon-Smith EC; Rochant H; Testa U
    Br J Haematol; 1984 Jan; 56(1):55-68. PubMed ID: 6538436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aberrant regulation of complement by the erythrocytes of hereditary erythroblastic multinuclearity with a positive acidified serum lysis test (HEMPAS).
    Tomita A; Parker CJ
    Blood; 1994 Jan; 83(1):250-9. PubMed ID: 7506081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defective glycosylation of erythrocyte membrane glycoconjugates in a variant of congenital dyserythropoietic anemia type II: association of low level of membrane-bound form of galactosyltransferase.
    Fukuda MN; Masri KA; Dell A; Thonar EJ; Klier G; Lowenthal RM
    Blood; 1989 Apr; 73(5):1331-9. PubMed ID: 2495036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural and functional consequences of an N-glycosylation mutation (HEMPAS) affecting human erythrocyte membrane glycoproteins.
    Kameh H; Landolt-Marticorena C; Charuk JH; Schachter H; Reithmeier RA
    Biochem Cell Biol; 1998; 76(5):823-35. PubMed ID: 10353717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation and characterization of poly-N-acetyllactosaminylceramides accumulated in the erythrocytes of congenital dyserythropoietic anemia type II patients.
    Fukuda MN; Bothner B; Scartezzini P; Dell A
    Chem Phys Lipids; 1986 Dec; 42(1-3):185-97. PubMed ID: 3829205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carbohydrate-deficient glycoprotein syndrome type II. An autosomal recessive N-acetylglucosaminyltransferase II deficiency different from typical hereditary erythroblastic multinuclearity, with a positive acidified-serum lysis test (HEMPAS).
    Charuk JH; Tan J; Bernardini M; Haddad S; Reithmeier RA; Jaeken J; Schachter H
    Eur J Biochem; 1995 Jun; 230(2):797-805. PubMed ID: 7607254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased glycosylation of band 3 and band 4.5 glycoproteins of erythrocyte membrane in congenital dyserythropoietic anaemia type II.
    Scartezzini P; Forni GL; Baldi M; Izzo C; Sansone G
    Br J Haematol; 1982 Aug; 51(4):569-76. PubMed ID: 7104237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new congenital dyserythropoietic anaemia.
    Ohisalo JJ; Viitala J; Lintula R; Ruutu T
    Br J Haematol; 1988 Jan; 68(1):111-4. PubMed ID: 3345287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polylactosamines are not obligate receptors for invasion of Plasmodium falciparum malaria as shown in HEMPAS variant II-gal- erythrocytes.
    Dhume ST; Adams-Burton CR; Shumak KH; Laine RA
    Glycobiology; 1994 Dec; 4(6):903-8. PubMed ID: 7734852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced deformability of erythrocytes as feature of congenital dyserythropoietic anaemia type II (HEMPAS).
    Izzo P; Spagnuolo A; Manicone A; Nazzaro P; Lauta VM
    Clin Hemorheol Microcirc; 1999; 21(3-4):425-30. PubMed ID: 10711781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Piebaldism associated with congenital dyserythropoietic anemia type II (HEMPAS).
    Köklü S; Ertuğrul D; Onat AM; Karakuş S; Haznedaroğlu IC; Büyükaşik Y; Sayinalp N; Ozcebe O; Dündar SV
    Am J Hematol; 2002 Mar; 69(3):210-3. PubMed ID: 11891809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Red cell membrane protein anomalies in congenital dyserythropoietic anaemia, type II (HEMP AS).
    Baines AJ; Banga JP; Gratzer WB; Linch DC; Huehns ER
    Br J Haematol; 1982 Apr; 50(4):563-74. PubMed ID: 7066206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Congenital disorders involving defective N-glycosylation of proteins.
    Schachter H
    Cell Mol Life Sci; 2001 Jul; 58(8):1085-104. PubMed ID: 11529501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Normal serum ferritin levels in a patient with HEMPAS syndrome and iron overload.
    Faruqui S; Abraham A; Berenfeld MR; Gabuzda TG
    Am J Clin Pathol; 1982 Jul; 78(1):97-101. PubMed ID: 7102612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.